Status:
COMPLETED
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
Lead Sponsor:
Pfizer
Conditions:
Plaque Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to investigate the incidences of adverse events for patients with plaque psoriasis treated with Enbrel under usual care settings.
Eligibility Criteria
Inclusion
- Proven diagnosis of Plaque Psoriasis
Exclusion
- Contraindications according to SmPC of Enbrel
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
753 Patients enrolled
Trial Details
Trial ID
NCT00227240
Start Date
April 1 2005
End Date
June 1 2009
Last Update
March 21 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Munich, Germany, 81366
2
Pfizer Investigational Site
München, Germany, 80337